Clinical Trial Update: Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma [EARLY_Phase 1]

View source ↗

Summary

An exploratory early-phase study evaluating a personalized mRNA vaccine in patients with refractory rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Personalized mRNA vaccine

Snippet

Sponsor: Xinxin Zhang | Conditions: Rhabdomyosarcoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING